FACTOR VIIa, RECOMBINANT helps to prevent or control bleeding in patients with hemophilia A or hemophilia B who have clotting factor inhibitors. This medicine may also be used to treat bleeding in patients with factor VII deficiency or in select patients who have other types of bleeding problems.\n \nThis medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. Get Novoseven RT for as low as $80,983.30, which is 8% off the average retail price of $87,871.96 for the most common version, by using a GoodRx coupon.